Literature DB >> 20845412

Antibacterials from the sea.

Chambers C Hughes1, William Fenical.   

Abstract

The ocean contains a host of macroscopic life in a great microbial soup. Unlike the terrestrial environment, an aqueous environment provides perpetual propinquity and blurs spatial distinctions. Marine organisms are under a persistent threat of infection by resident pathogenic microbes including bacteria, and in response they have engineered complex organic compounds with antibacterial activity from a diverse set of biological precursors. The diluting effect of the ocean drives the construction of potent molecules that are stable to harsh salty conditions. Members of each class of metabolite-ribosomal and non-ribosomal peptides, alkaloids, polyketides, and terpenes-have been shown to exhibit antibacterial activity. The sophistication and diversity of these metabolites points to the ingenuity and flexibility of biosynthetic processes in Nature. Compared with their terrestrial counterparts, antibacterial marine natural products have received much less attention. Thus, a concerted effort to discover new antibacterials from marine sources has the potential to contribute significantly to the treatment of the ever increasing drug-resistant infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20845412      PMCID: PMC3071975          DOI: 10.1002/chem.201001279

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  138 in total

1.  Engineered salt-insensitive alpha-defensins with end-to-end circularized structures.

Authors:  Q Yu; R I Lehrer; J P Tam
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

2.  YM-266183 and YM-266184, novel thiopeptide antibiotics produced by Bacillus cereus isolated from a marine sponge. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological properties.

Authors:  Koji Nagai; Kazuma Kamigiri; Nakako Arao; Ken-ichi Suzumura; Yasuhiro Kawano; Masakazu Yamaoka; Huiping Zhang; Masato Watanabe; Kenichi Suzuki
Journal:  J Antibiot (Tokyo)       Date:  2003-02       Impact factor: 2.649

3.  Cationic antimicrobial peptides: update of clinical development.

Authors:  E Andrès; J L Dimarcq
Journal:  J Intern Med       Date:  2004-04       Impact factor: 8.989

4.  New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates.

Authors:  Aaron M Socha; Kerry L LaPlante; David C Rowley
Journal:  Bioorg Med Chem       Date:  2006-09-18       Impact factor: 3.641

Review 5.  Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria.

Authors:  Peter C Appelbaum; Michael R Jacobs
Journal:  Curr Opin Microbiol       Date:  2005-10       Impact factor: 7.934

Review 6.  Empirical antibacterial drug discovery--foundation in natural products.

Authors:  Sheo B Singh; John F Barrett
Journal:  Biochem Pharmacol       Date:  2006-01-19       Impact factor: 5.858

7.  Antibiotic bisanthraquinones produced by a streptomycete isolated from a cyanobacterium associated with Ecteinascidia turbinata.

Authors:  Aaron M Socha; Dioscaris Garcia; Roberta Sheffer; David C Rowley
Journal:  J Nat Prod       Date:  2006-07       Impact factor: 4.050

8.  Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.

Authors:  I H Lee; C Zhao; Y Cho; S S Harwig; E L Cooper; R I Lehrer
Journal:  FEBS Lett       Date:  1997-01-03       Impact factor: 4.124

9.  Total syntheses of thiocoraline and BE-22179 and assessment of their DNA binding and biological properties.

Authors:  D L Boger; S Ichikawa; W C Tse; M P Hedrick; Q Jin
Journal:  J Am Chem Soc       Date:  2001-01-31       Impact factor: 15.419

10.  Isolation of three new antibiotics, thiocillins I, II and III, related to micrococcin P. Studies on antibiotics from the genus Bacillus. VIII.

Authors:  J Shoji; H Hinoo; Y Wakisaka; K Koizumi; M Mayama
Journal:  J Antibiot (Tokyo)       Date:  1976-04       Impact factor: 2.649

View more
  43 in total

Review 1.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

Review 2.  Highlights of marine invertebrate-derived biosynthetic products: their biomedical potential and possible production by microbial associants.

Authors:  Ocky K Radjasa; Yvette M Vaske; Gabriel Navarro; Hélène C Vervoort; Karen Tenney; Roger G Linington; Phillip Crews
Journal:  Bioorg Med Chem       Date:  2011-07-26       Impact factor: 3.641

Review 3.  From the raw bar to the bench: Bivalves as models for human health.

Authors:  José A Fernández Robledo; Raghavendra Yadavalli; Bassem Allam; Emmanuelle Pales Espinosa; Marco Gerdol; Samuele Greco; Rebecca J Stevick; Marta Gómez-Chiarri; Ying Zhang; Cynthia A Heil; Adrienne N Tracy; David Bishop-Bailey; Michael J Metzger
Journal:  Dev Comp Immunol       Date:  2018-11-29       Impact factor: 3.636

Review 4.  Antimicrobial Lipids from Plants and Marine Organisms: An Overview of the Current State-of-the-Art and Future Prospects.

Authors:  Eliana Alves; Marina Dias; Diana Lopes; Adelaide Almeida; Maria do Rosário Domingues; Felisa Rey
Journal:  Antibiotics (Basel)       Date:  2020-07-24

Review 5.  Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance.

Authors:  Fernando Baquero; Teresa M Coque; Fernando de la Cruz
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

6.  Padanamides A and B, highly modified linear tetrapeptides produced in culture by a Streptomyces sp. isolated from a marine sediment.

Authors:  David E Williams; Doralyn S Dalisay; Brian O Patrick; Teatulohi Matainaho; Kerry Andrusiak; Raamesh Deshpande; Chad L Myers; Jeff S Piotrowski; Charles Boone; Minoru Yoshida; Raymond J Andersen
Journal:  Org Lett       Date:  2011-07-12       Impact factor: 6.005

7.  Seriniquinone, a selective anticancer agent, induces cell death by autophagocytosis, targeting the cancer-protective protein dermcidin.

Authors:  Lynnie Trzoss; Takashi Fukuda; Letícia V Costa-Lotufo; Paula Jimenez; James J La Clair; William Fenical
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-30       Impact factor: 11.205

Review 8.  Natural products: a continuing source of novel drug leads.

Authors:  Gordon M Cragg; David J Newman
Journal:  Biochim Biophys Acta       Date:  2013-02-18

9.  Two Streptomyces species producing antibiotic, antitumor, and anti-inflammatory compounds are widespread among intertidal macroalgae and deep-sea coral reef invertebrates from the central Cantabrian Sea.

Authors:  Alfredo F Braña; Afredo F Braña; Hans-Peter Fiedler; Herminio Nava; Verónica González; Aida Sarmiento-Vizcaíno; Axayacatl Molina; José L Acuña; Luis A García; Gloria Blanco
Journal:  Microb Ecol       Date:  2014-10-16       Impact factor: 4.552

10.  In vitro anti-biofilm and anti-bacterial activity of Junceella juncea for its biomedical application.

Authors:  P Kumar; S Senthamil Selvi; M Govindaraju
Journal:  Asian Pac J Trop Biomed       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.